| BioVision |
2074-1 |
Rhapontigenin
|
1 mg |
|
|
| BioVision |
2072-25 |
Piceatannol
|
25 mg |
|
|
| BioVision |
2073-5 |
Pterostilbene
|
5 mg |
|
|
| BioVision |
2072-5 |
Piceatannol
|
5 mg |
|
|
| BioVision |
2069-1 |
TAPI-2
|
1 mg |
|
|
| BioVision |
2070-1 |
Bromodomain Inhibitor, (+)-JQ1
|
1 mg |
|
|
| BioVision |
2070-5 |
Bromodomain Inhibitor, (+)-JQ1
|
5 mg |
|
|
| BioVision |
2065-100 |
FeTPPS
|
100 mg |
|
|
| BioVision |
2067-1 |
TAPI-0
|
1 mg |
|
|
| BioVision |
2068-1 |
TAPI-1
|
1 mg |
|
|
| BioVision |
2066-5 |
Kartogenin
|
5 mg |
|
|
| BioVision |
2066-25 |
Kartogenin
|
25 mg |
|
|
| BioVision |
2065-25 |
FeTPPS
|
25 mg |
|
|
| BioVision |
2062-5 |
Sirtinol
|
5 mg |
|
|
| BioVision |
2063-1 |
Wnt Antagonist, C59
|
1 mg |
|
|
| BioVision |
2063-5 |
Wnt Antagonist, C59
|
5 mg |
|
|
| BioVision |
2064-5 |
Chelerythrine chloride
|
5 mg |
|
|
| BioVision |
2062-1 |
Sirtinol
|
1 mg |
|
|
| BioVision |
2061-5 |
YC-1
|
5 mg |
|
|
| BioVision |
2061-25 |
YC-1
|
25 mg |
|
|
| BioVision |
2059-50 |
Leukadherin-1
|
50 mg |
|
|
| BioVision |
2060-250 |
3-Deazaneplanocin A
|
250 µg |
|
|
| BioVision |
2060-1000 |
3-Deazaneplanocin A
|
1 mg |
|
|
| BioVision |
2058-50 |
MnTBAP Chloride
|
50 mg |
|
|
| BioVision |
2059-10 |
Leukadherin-1
|
10 mg |
|
|
| BioVision |
2058-10 |
MnTBAP Chloride
|
10 mg |
|
|
| BioVision |
2056-50 |
MnTMPyP Pentachloride
|
50 mg |
|
|
| BioVision |
2057-5 |
GW1929
|
5 mg |
|
|
| BioVision |
2057-25 |
GW1929
|
25 mg |
|
|
| BioVision |
2055-25 |
1400W dihydrochloride
|
25 mg |
|
|
| BioVision |
2056-10 |
MnTMPyP Pentachloride
|
10 mg |
|
|
| BioVision |
2055-5 |
1400W dihydrochloride
|
5 mg |
|
|
| BioVision |
2054-10 |
PK 11195
|
10 mg |
|
|
| BioVision |
2054-50 |
PK 11195
|
50 mg |
|
|
| BioVision |
2053-5 |
Pellitorine
|
5 mg |
|
|
| BioVision |
2053-1 |
Pellitorine
|
1 mg |
|
|
| BioVision |
2052-5 |
PKC412
|
5 mg |
|
|
| BioVision |
2050-1000 |
TAME Hydrochloride
|
1 g |
|
|
| BioVision |
2051-10 |
ODQ
|
10 mg |
|
|
| BioVision |
2051-50 |
ODQ
|
50 mg |
|
|
| BioVision |
2052-1 |
PKC412
|
1 mg |
|
|
| BioVision |
2050-500 |
TAME Hydrochloride
|
500 mg |
|
|
| BioVision |
2047-5 |
Sphingosine Kinase Inhibitor, SKI-II
|
5 mg |
|
|
| BioVision |
2050-100 |
TAME Hydrochloride
|
100 mg |
|
|
| BioVision |
2047-25 |
Sphingosine Kinase Inhibitor, SKI-II
|
25 mg |
|
|
| BioVision |
2048-100 |
Erlotinib, Free Base
|
100 mg |
|
|
| BioVision |
2048-1000 |
Erlotinib, Free Base
|
1 g |
|
|
| BioVision |
2046-5 |
Sphingosine Kinase Inhibitor, SKI-I
|
5 mg |
|
|
| BioVision |
2046-25 |
Sphingosine Kinase Inhibitor, SKI-I
|
25 mg |
|
|
| BioVision |
2045-5 |
YM201636
|
5 mg |
|
|